News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Astellas Pharma Inc. and Pfizer Japan Inc. Release: Announcement of the Launch of the Selective COX-2 Inhibitor Celecox(R) Tablets in Japan



6/13/2007 1:17:26 PM

Tokyo, June 11, 2007 (JCN Newswire) - Astellas Pharma Inc. and Pfizer Japan Inc. today announced that their selective COX-2 inhibitor Celecox(R)(generic name: celecoxib), a non-steroidal anti-inflammatory drug (NSAID), will become available in Japan on June 12, 2007, with the indication of "relief of inflammation and pain associated with rheumatoid arthritis (RA) and osteoarthritis (OA)".

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES